Skip to Content
Company Analyst
Peter Lawson, DPhil (Oxon)
Goldman Sachs
Chris Shibutani, M.D.
Charles Zhu, Ph.D.
H.C. Wainwright
Robert Burns
SVB Securities
Andrew Berens, M.D.
Robert Driscoll, Ph.D.

Tango Therapeutics, Inc is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Tango Therapeutics, Inc's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Tango Therapeutics, Inc or its management. Tango Therapeutics, Inc does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.